Holen Sie sich die Stockscreener-App
14.85
7.61%
1.05
Vorhandelsmarkt:
14.85
Schlusskurs vom Vortag:
$13.80
Offen:
$13.63
24-Stunden-Volumen:
2.51M
Relative Volume:
1.53
Marktkapitalisierung:
$1.02B
Einnahmen:
$2.66B
Nettoeinkommen (Verlust:
$-1.21B
KGV:
-0.8333
EPS:
-17.82
Netto-Cashflow:
$-159.40M
1W Leistung:
-1.59%
1M Leistung:
-10.43%
6M Leistung:
-33.94%
1J Leistung:
-43.62%
1-Tages-Spanne:
$13.51
$15.20
1-Wochen-Bereich:
$13.21
$15.26
52-Wochen-Spanne:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Firmenname
Quidelortho Corp
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
14.85 | 946.34M | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corp Aktie (QDEL) Neueste Nachrichten
QuidelOrtho (NASDAQ:QDEL) Shares Up 6.9%Here's What Happened - MarketBeat
QuidelOrtho Corporation’s Margin Recovery Meets China, Respiratory & Cash Flow Headwinds ! - Smartkarma
QuidelOrtho EVP Bryan Hanson Reports RSU Vesting and Tax-Related Share Withholding - Kalkine Media
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript - AOL.com
QuidelOrtho (QDEL) Earnings Check: Reported EPS Tops Expectations for the Current Session; Market Follow-Through: Shares Close 8.44% LowerLow Estimate Range - Vinanet
Quidelortho Corp (QDEL) News, Articles, Events & Latest Updates - Stocktwits
Rice Hall James & Associates LLC Invests $18.63 Million in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed - Yahoo Finance
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers - StockStory
QuidelOrtho Corp (QDEL) Stock Down 5.2% -- Now Undervalued? GF S - GuruFocus
QuidelOrtho (NASDAQ:QDEL) Stock Rating Lowered by Zacks Research - MarketBeat
QDEL|QuidelOrtho Corp|Price:14.300|Chg%:-0.790 - TradingKey
QuidelOrtho (QDEL) Is Down 7.5% After Cutting 2026 Revenue Outlook Amid Softer COVID Testing Demand - simplywall.st
Invesco Ltd. (QDEL holder) reports 5.1% beneficial stake in QuidelOrtho Corp - Stock Titan
QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations - Yahoo Finance
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Up 6.0% and Still Undervalued -- G - GuruFocus
Neuberger Berman Group LLC Trims QuidelOrtho Corp (QDEL) Stake -- Shares Trade 59% Below GF Value - GuruFocus
Why QuidelOrtho (QDEL) Stock Is Nosediving - Yahoo Finance
QuidelOrtho partially recovers from earnings slide, rising 12% (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Up 8.5%Should You Buy? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging - Yahoo Finance
QuidelOrtho Corporation revenue up 3% to USD 631M in Q2 2026 - Medical Buyer
QuidelOrtho Corp (QL1A.DU) options chain - Yahoo Finance Australia
QuidelOrtho (QDEL) Stock Sinks As Cash Burn And Debt Eclipse Progress - Sahm
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July - Benzinga
QuidelOrtho Corporation 2026 Q2ResultsEarnings Call Presentation (NASDAQ:QDEL) 2026-08-07 - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownTime to Sell? - MarketBeat
QuidelOrtho Corp (QDEL) Stock News Today - TradingKey
QuidelOrtho stock drops after Q2 results (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
QuidelOrtho 2Q Rev $630.9M >QDEL - Moomoo
AUG 06 (REUTERS)QUIDELORTHO Q2 REVENUE USD 630.9 MILLION. - Moomoo
QuidelOrtho Q2 Earnings Call Highlights - MarketBeat
QuidelOrtho Corp Q2 2026: Revenue $630.9M, EPS $(1.36) — 10-Q Summary - TradingView
QuidelOrtho Corp Quarterly Earnings Report - Stock Titan
QuidelOrtho Corp (QDEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QuidelOrtho (NASDAQ:QDEL) Issues FY 2026 Earnings Guidance - MarketBeat
Has QuidelOrtho Corp (QDEL) Undervalued Potential After Q2 Earni - GuruFocus
Earnings call transcript: QuidelOrtho beats Q2 2026 estimates but cuts outlook - Investing.com
QuidelOrtho (NASDAQ:QDEL) Posts Earnings Results, Beats Estimates By $0.18 EPS - MarketBeat
QuidelOrtho Corp reports results for the quarter ended June 30Earnings Summary - TradingView
QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Surprises With Q2 CY2026 Sales But Stock Drops 21.6% - StockStory
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q2 Adjusted EPS $0.13 per Share - marketscreener.com
Q2 2026 QuidelOrtho Corp Earnings Call Transcript - GuruFocus
QuidelOrtho: Q2 Earnings Snapshot - marketscreener.com
QuidelOrtho posts Q2 2026 revenue $631M, adjusted EBITDA $129M and revises full-year guidance - TradingView
QuidelOrtho (Nasdaq: QDEL) trims 2026 revenue and EPS guidance - Stock Titan
QuidelOrtho Reports Second Quarter 2026 Financial Results - marketscreener.com
QuidelOrtho Q2 Sales Rose 3% as China Revenue Fell 18.7% - Stock Titan
Finanzdaten der Quidelortho Corp-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):